My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 204

    1.

    Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.

    Braun RP, Payne LG, Dong L.

    Virol J. 2006 Jul 5;3:54.PMID: 16822314 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.

    Koelle DM, Chen HB, Gavin MA, Wald A, Kwok WW, Corey L.

    J Immunol. 2001 Mar 15;166(6):4049-58.PMID: 11238653 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions.

    Koelle DM, Frank JM, Johnson ML, Kwok WW.

    J Virol. 1998 Sep;72(9):7476-83.PMID: 9696844 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?

    Posavad CM, Wald A, Hosken N, Huang ML, Koelle DM, Ashley RL, Corey L.

    J Immunol. 2003 Apr 15;170(8):4380-8.PMID: 12682275 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.

    Kim M, Taylor J, Sidney J, Mikloska Z, Bodsworth N, Lagios K, Dunckley H, Byth-Wilson K, Denis M, Finlayson R, Khanna R, Sette A, Cunningham AL.

    J Immunol. 2008 Nov 1;181(9):6604-15.PMID: 18941251 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.

    Harandi AM, Svennerholm B, Holmgren J, Eriksson K.

    J Gen Virol. 2001 Apr;82(Pt 4):845-53.PMID: 11257190 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Characterization of T cell responses to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISpot cytokine assay.

    Schmid DS, Thieme ML, Gary HE Jr, Reeves WC.

    Arch Virol. 1997;142(8):1659-71.PMID: 9672626 [PubMed - indexed for MEDLINE]Related articles

    9.

    Homing in on the cellular immune response to HSV-2 in humans.

    Koelle DM, Gonzalez JC, Johnson AS.

    Am J Reprod Immunol. 2005 Apr;53(4):172-81.PMID: 15760378 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.

    Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.

    Cytometry B Clin Cytom. 2008 Jul;74(4):211-20.PMID: 18454493 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production.

    Mikloska Z, Rückholdt M, Ghadiminejad I, Dunckley H, Denis M, Cunningham AL.

    J Immunol. 2000 May 15;164(10):5167-76.PMID: 10799875 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens.

    Shahemabadi AS, Hosseini AZ, Shaghsempour S, Masjedi MR, Rayani M, Pouramiri M.

    Clin Exp Immunol. 2007 Aug;149(2):285-94. Epub 2007 May 9.PMID: 17490401 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection.

    Singh R, Kumar A, Creery WD, Ruben M, Giulivi A, Diaz-Mitoma F.

    Clin Exp Immunol. 2003 Jul;133(1):97-107.PMID: 12823283 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.

    Svensson A, Nordström I, Sun JB, Eriksson K.

    J Immunol. 2005 May 15;174(10):6266-73.PMID: 15879125 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Development of a therapeutic vaccine for HSV-2.

    Hosken NA.

    Vaccine. 2005 Mar 18;23(17-18):2395-8.PMID: 15755634 [PubMed - indexed for MEDLINE]Related articles

    17.

    Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.

    Sacre K, Carcelain G, Cassoux N, Fillet AM, Costagliola D, Vittecoq D, Salmon D, Amoura Z, Katlama C, Autran B.

    J Exp Med. 2005 Jun 20;201(12):1999-2010.PMID: 15967826 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.

    Hosken N, McGowan P, Meier A, Koelle DM, Sleath P, Wagener F, Elliott M, Grabstein K, Posavad C, Corey L.

    J Virol. 2006 Jun;80(11):5509-15.PMID: 16699031 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.
    20.

    Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.

    Koelle DM, Corey L, Burke RL, Eisenberg RJ, Cohen GH, Pichyangkura R, Triezenberg SJ.

    J Virol. 1994 May;68(5):2803-10.PMID: 7512152 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk